In a victory for Gilead, Brazilian antitrust authorities dismissed a complaint alleging the company charged “abusive” prices for a hepatitis C treatment.
As new cancer drugs arrive, regulators and doctors still struggle with when to use drugs based on earlier data and when to wait for survival data. #ASCO23 […]
Ginkgo, a company that said its engineered cells could help make almost anything, is trying to drum up business. […]
“I had this kind of naive view that if you start with the same cell every time, and you run the same process, every time, then you’re going to end… […]